Review



aro dm1  (Arrowhead Pharmaceuticals)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Arrowhead Pharmaceuticals aro dm1
    Aro Dm1, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aro-dm1/aro+dm1/pm41549990-185-33-0
    Average 86 stars, based on 1 article reviews
    aro dm1 - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    Medications:

    Article Title: Development, opportunities, and challenges of siRNA nucleic acid drugs
    Article Snippet: The following medications are undergoing phase 1 clinical trials in Arrowhead Pharmaceuticals’ pipeline ( ): ARO-PNPLA3, ARO-C3, ARO-CFB, ARO-MUC5AC, ARO-RAGE, ARO-MMP7, ARO-DUX4, ARO-DM1, ARO-SOD1, and HZN-457.

    Article Title: Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver.
    Article Snippet: Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy. https://ir.arrowheadpharma.com/news-releases/news-release-details/ arrowhead-pharmaceuticals-initiates-phase-12a-study-aro-dm1 (8 March 2024). (163) Pei, D.; Buyanova, M. Overcoming endosomal entrapment in drug delivery.

    Article Title: Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.
    Article Snippet: Arrowhead Pharmaceuticals’ ARO-DM1, an RNAi therapeutic targeting the DMPK gene, has shown preclinical efficacy, with an 80% reduction in DMPK mRNA in non-human primate muscles (NCT06138743; Phase I/IIa).

    Article Title: Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective
    Article Snippet: Arrowhead Pharmaceuticals’ ARO-DM1, an RNAi therapeutic targeting the DMPK gene, has shown preclinical efficacy, with an 80% reduction in DMPK mRNA in non-human primate muscles ( NCT06138743 ; Phase I/IIa).

    Clinical Proteomics:

    Article Title: Development, opportunities, and challenges of siRNA nucleic acid drugs
    Article Snippet: The following medications are undergoing phase 1 clinical trials in Arrowhead Pharmaceuticals’ pipeline ( ): ARO-PNPLA3, ARO-C3, ARO-CFB, ARO-MUC5AC, ARO-RAGE, ARO-MMP7, ARO-DUX4, ARO-DM1, ARO-SOD1, and HZN-457.

    Article Title: Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver.
    Article Snippet: Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-DM1 for Treatment of Type 1 Myotonic Dystrophy. https://ir.arrowheadpharma.com/news-releases/news-release-details/ arrowhead-pharmaceuticals-initiates-phase-12a-study-aro-dm1 (8 March 2024). (163) Pei, D.; Buyanova, M. Overcoming endosomal entrapment in drug delivery.

    Article Title: Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.
    Article Snippet: Arrowhead Pharmaceuticals’ ARO-DM1, an RNAi therapeutic targeting the DMPK gene, has shown preclinical efficacy, with an 80% reduction in DMPK mRNA in non-human primate muscles (NCT06138743; Phase I/IIa).

    Article Title: Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective
    Article Snippet: Arrowhead Pharmaceuticals’ ARO-DM1, an RNAi therapeutic targeting the DMPK gene, has shown preclinical efficacy, with an 80% reduction in DMPK mRNA in non-human primate muscles ( NCT06138743 ; Phase I/IIa).



    Similar Products

    aro dm1  (Arrowhead Pharmaceuticals)
    86
    Arrowhead Pharmaceuticals aro dm1
    Aro Dm1, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aro-dm1/aro+dm1/pm41549990-185-33-0
    Average 86 stars, based on 1 article reviews
    aro dm1 - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    aro-dm1  (Arrowhead Pharmaceuticals)
    90
    Arrowhead Pharmaceuticals aro-dm1
    Aro Dm1, supplied by Arrowhead Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/aro-dm1/aro+dm1/pm40508159-309-2-0
    Average 90 stars, based on 1 article reviews
    aro-dm1 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results